12个病种中医临床诊疗指南应用性评价

Evaluation of the applicability of TCM clinical practice guideline in 12 diseases

目的:评价2008年和2012年颁布的12个病种中医临床诊疗指南的临床应用性。方法:采用国家中医药管理局统一设计的《中医临床诊疗指南应用评价病例调查表》,由临床医务人员填写,并进行统计分析。结果:指南总体疗效的有效率除健忘为98.33%,其余11个病种的有效率为100%;指南安全性评价的安全率除健忘,Ig A肾病,原发性血小板减少性紫癜为98.33%、96.67%、98.33%,其余9个病种的安全率均为100%;12个病种指南经济性评价的经济比率从65.00%-100%;2012版指南临床评价符合率除预防调摄和其他治法外均优于2008版(P<0.001);2012版指南综合评价中技术水平、满意度和适用性的得分优于2008版(P<0.01)。结论:2012版指南临床评价、综合评分情况优于2008版,建议及时评价指南的临床应用性情况,更新修订,并加大指南的推广力度。

Objective:To evaluate the applicability of TCM clinical practice guidelines issued in 2008 and 2012.Methods:Application of TCM Clinical Guidelines Case Report Questionnaire filled in by doctor was used and statistically analyzed.Results:The overall effective rate of the guideline except the amnesia was 98.33%;the effective rate of the rest 11 kinds was 100%.The safety ratios of amnesia,Ig A nephropathy,and idiopathic thrombocytopenic purpura were respectively 98.33%,96.67%,and 98.33%.Others' safety ratio was 100%.Economic evaluation ratio was from 65.00% to 100%.Conform rate of 2012 version for clinical evaluation were better than the 2008 version except prevention and other treatment(P<0.001).The scores of technical level and the satisfaction and the applicability in the comprehensive evaluation for 2012 version were better than 2008 version(P<0.01).Conclusion:The guideline of 2012 version for clinical evaluation and comprehensive score was better than 2008 version.It is advised to evaluate application situation of guidelines timely,update the revision,and strengthen the promotion.